Trade KOD stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Kodiak Sciences Inc (KOD) is trading at US$91.08, down 1.36% today as of Oct 7, 16:00 EDT. The company has a market capitalisation of US$2.41B. Over the past 52 weeks, KOD has traded between US$10.94 and US$104.00. On Syfe you can trade KOD with $0 commission and add it to your watchlist.
| Previous close | US$92.34 |
|---|---|
| Market cap | US$2.41B |
| 52-week range | US$10.94 – US$104.00 |
| Volume | 1.3M |
| Exchange | US |
Kodiak Sciences Inc
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.
Year: 2018
Kodiak Sciences Inc (KOD) stock is trading at US$91.08, -1.36% from the previous close of US$92.34.
The market cap for Kodiak Sciences Inc (KOD) stock is approximately US$2.41B.
The 52-week high for Kodiak Sciences Inc (KOD) stock is US$104.00.
The 52-week low for Kodiak Sciences Inc (KOD) stock is US$10.94.
Kodiak Sciences Inc (KOD) does not currently pay a dividend.
Stay on top of KOD
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
